Lightcalls.com
 

OTHER NAMES Ginger rhizome PART U...

OTHER NAMES Ginger rhizome

PART USED Rhizome

USES

* Primary uses: Nausea appropriate to motion sickness, morning sickness, stomach virus, digestive disorders and chemotherapy.

* Uses approved by way of the German Commission E: Nausea proper to dyspepsia and motion sickness.

approveed FORMS AND AMOUNTS

* dusted rhizome: 0.25-1.0 gram three times daily.

* Standardized extract or freeze-dried rhizome: For motion sickness: brace 250 mg capsules 30 minutes before wait fored symptoms, then two capsules each 2 hours.

* Tincture (1:5 concentration): 025-10 mL three times daily.



* Fluid extract (1:1 concentration): 125-50 mL three times daily.

* Tea: Simmer 025-1 gram whole gingerroot in 150 mL water for 15 minutes three times daily. Drink when moderately colded Extra tea can be made in advance, stored in an airtight container and refrigerated.

* Children in subordination to the age of 6: 1/2 the adult dose.

* Pregnant women: up to 1 gram daily for short-term use.

SIDE EFFECTS/DRUG INTERACTIONS In therapeutic amounts, ginger may increase bleeding time and curtail platelet stickiness. So people scheduled for surgery or forward platelet-inhibiting drugs should consult a physician. Ginger may also cause heartburn.

CONTRAINDICATIONS Because it may increase bleeding, the public on blood thinners and pregnant women cease to delivery or at risk of premature delivery should not use ginger in therapeutic amounts. population with gallstones should consult a licensed health care practitioner trained in the use of botanical medicine before using ginger.

SAFETY IN PREGNANCY AND LACTATION The Commission E does not approve the use of ginger during pregnancy. According to a review course of lifeed by Fulder and Tenne (1996) however, there is no evidence that ginger causes harm to the fetus or mother in the amounts make acceptableed for nausea. The vice president of the Commission E Professor Heinz Schilcher, agrees (Schilcher, 1998) Licensed health care professionals trained in botanical medicine consider ginger safe and effective in succession a short-term basis for morning sickness in healthy mothers during the first trimester of pregnancy. Pregnant women using 1 gram or more by day of ginger should do in the way that under physician supervision.

COPYRIGHT 2005 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2005 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.